ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

8 hedge funds and large institutions have $1.03M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

38% less capital invested

Capital invested by funds: $1.67M → $1.03M (-$634K)

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$266K
Puts
$301K
Net Calls
Net Calls Change

Top Buyers

1
+$104K
2
+$104K
3
+$38.5K
4
VF
Virtu Financial
New York
+$12.3K

Top Sellers

1
-$319K
2
-$260K
3
-$2.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$659K
2
$108K
3
$104K
4
$104K
5
$41K
6
$8K
7
$7K
8
–